Literature DB >> 9926284

Tissue kallikreins structure, regulation, and participation in mammalian physiology and disease.

H S Margolius1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9926284     DOI： 10.1007/BF02737655

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  47 in total

1.  Sites of glandular kallikrein gene expression in fetal mice.

Authors:  J D Penschow; J P Coghlan
Journal:  Mol Cell Endocrinol       Date:  1992-10       Impact factor: 4.102

Review 2.  Bioregulation of kinins: kallikreins, kininogens, and kininases.

Authors:  K D Bhoola; C D Figueroa; K Worthy
Journal:  Pharmacol Rev       Date:  1992-03       Impact factor: 25.468

3.  Renal kallikrein content of spontaneously hypertensive rats.

Authors:  S Favaro; B Baggio; A Antonello; A Zen; G Cannella; S Todesco; A Borsatti
Journal:  Clin Sci Mol Med       Date:  1975-07

4.  Modulation of the cell membrane expression of the kininogens regulates the rate of bradykinin delivery to cells.

Authors:  A H Schmaier
Journal:  Trends Cardiovasc Med       Date:  1992 May-Jun       Impact factor: 6.677

5.  Renal kallikrein and hemodynamic abnormalities of diabetic kidney.

Authors:  J N Harvey; A A Jaffa; H S Margolius; R K Mayfield
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

6.  Cosegregation of blood pressure with a kallikrein gene family polymorphism.

Authors:  M Pravenec; V Kren; J Kunes; A G Scicli; O A Carretero; L Simonet; T W Kurtz
Journal:  Hypertension       Date:  1991-02       Impact factor: 10.190

7.  Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.

Authors:  N B Oza; J H Schwartz; H D Goud; N G Levinsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Characterization of the human kallikrein locus.

Authors:  P H Riegman; R J Vlietstra; L Suurmeijer; C B Cleutjens; J Trapman
Journal:  Genomics       Date:  1992-09       Impact factor: 5.736

9.  Renal excretion of kallikrein and eicosanoids in patients with type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function.

Authors:  J N Harvey; A W Edmundson; A A Jaffa; L L Martin; R K Mayfield
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

10.  Glomerular B2-kinin-binding sites in two-kidney, one-clip hypertensive rats.

Authors:  C Emond; J L Bascands; J Rakotoarivony; F Praddaude; G Bompart; C Pecher; J L Ader; J P Girolami
Journal:  Am J Physiol       Date:  1991-05
View more
  3 in total

Review 1.  Cross-talk between the complement and the kinin system in vascular permeability.

Authors:  Fleur Bossi; Ellinor I Peerschke; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Immunol Lett       Date:  2011-07-06       Impact factor: 3.685

2.  Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.

Authors:  Berhane Ghebrehiwet; Jolyon Jesty; Sulan Xu; Rama Vinayagasundaram; Uma Vinayagasundaram; Yan Ji; Alisa Valentino; Kinga K Hosszu; Sally Mathew; Kusumam Joseph; Allen P Kaplan; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2011-11-01       Impact factor: 7.561

3.  Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis.

Authors:  Darian Williams; Marwa Mahmoud; Renfa Liu; Aitor Andueza; Sandeep Kumar; Dong-Won Kang; Jiahui Zhang; Ian Tamargo; Nicolas Villa-Roel; Kyung-In Baek; Hwakyoung Lee; Yongjin An; Leran Zhang; Edward W Tate; Pritha Bagchi; Jan Pohl; Laurent O Mosnier; Eleftherios P Diamandis; Koichiro Mihara; Morley D Hollenberg; Zhifei Dai; Hanjoong Jo
Journal:  Elife       Date:  2022-01-11       Impact factor: 8.713
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.